MERRIMACK PHARMACEUTICALS IN's ticker is MACK and the CUSIP is 590328209. A total of 52 filers reported holding MERRIMACK PHARMACEUTICALS IN in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $11,220 | +461.0% | 910 | -17.5% | 0.00% | – |
| Q1 2020 | $2,000 | -96.9% | 1,103 | -94.8% | 0.00% | – |
| Q4 2019 | $65,000 | -43.0% | 21,131 | -17.5% | 0.00% | – |
| Q3 2019 | $114,000 | -26.5% | 25,622 | -0.8% | 0.00% | – |
| Q2 2019 | $155,000 | -24.0% | 25,822 | -12.6% | 0.00% | – |
| Q1 2019 | $204,000 | +90.7% | 29,546 | +5.7% | 0.00% | – |
| Q4 2018 | $107,000 | -67.0% | 27,946 | -54.1% | 0.00% | – |
| Q3 2018 | $324,000 | +39.7% | 60,892 | +27.2% | 0.00% | – |
| Q2 2018 | $232,000 | -89.0% | 47,886 | -81.8% | 0.00% | -100.0% |
| Q1 2018 | $2,113,000 | +43.6% | 262,701 | +82.7% | 0.00% | 0.0% |
| Q4 2017 | $1,471,000 | -36.3% | 143,770 | -9.5% | 0.00% | -50.0% |
| Q3 2017 | $2,308,000 | – | 158,849 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Western Standard LLC | 1,894,013 | $23,353,180 | 21.09% |
| Newtyn Management, LLC | 1,873,694 | $23,102,647 | 5.70% |
| Sio Capital Management, LLC | 288,466 | $3,556,786 | 1.10% |
| Madison Avenue Partners, LP | 553,085 | $6,819,538 | 0.97% |
| WITTENBERG INVESTMENT MANAGEMENT, INC. | 209,739 | $2,586 | 0.95% |
| Indaba Capital Management, L.P. | 136,802 | $1,686,769 | 0.50% |
| Sepio Capital, LP | 306,680 | $3,781,364 | 0.33% |
| Yakira Capital Management, Inc. | 54,118 | $667,275 | 0.18% |
| Centiva Capital, LP | 187,803 | $2,315,611 | 0.05% |
| FIFTH LANE CAPITAL, LP | 10,929 | $134,427 | 0.05% |